Zydus Wellness FY21 net profit falls 16% to Rs 119 cr

Zydus Wellness FY21 net profit falls 16% to Rs 119 cr

For January-March quarter, the consumer wellness company's net profit grew over 92 per cent to Rs 133 crore, while total revenue rose 24 per cent to Rs 608 crore.

Advertisement
During the quarter, the company also forayed in the dairy segment with launch of two new products under the 'Nutralite' brand.During the quarter, the company also forayed in the dairy segment with launch of two new products under the 'Nutralite' brand.
BusinessToday.In
  • May 10, 2021,
  • Updated May 10, 2021 4:11 PM IST

Zydus Wellness on Monday reported a 16 per cent year-on-year decline in its consolidated net profit for financial year 2020-21 at Rs 119 crore.

The company's net profit would have been about 35 per cent higher at Rs 251 crore if not for exceptional item of Rs 132 crore during the year.

Advertisement

"The secured non-convertible debentures that were previously issued by the company has been purchased by its subsidiary company from the market aggregating to Rs 1,105 crore and Rs 395 crore in the respective quarter ended September 30, 2020 and December 31, 2020. The company has redeemed all the NCDs of Rs 1,500 crore and the premium amount paid towards purchase of the above NCDs are expensed off as an exceptional items in the aforesaid results for the year ended March 31, 2021," Zydus Wellness said.

The company's total revenue rose 5.5 per cent to Rs 1,875 crore during FY21.

All you need to know about DRDO's new anti-COVID-19 drug 2-DG

Zydus Wellness on Monday reported a 16 per cent year-on-year decline in its consolidated net profit for financial year 2020-21 at Rs 119 crore.

The company's net profit would have been about 35 per cent higher at Rs 251 crore if not for exceptional item of Rs 132 crore during the year.

Advertisement

"The secured non-convertible debentures that were previously issued by the company has been purchased by its subsidiary company from the market aggregating to Rs 1,105 crore and Rs 395 crore in the respective quarter ended September 30, 2020 and December 31, 2020. The company has redeemed all the NCDs of Rs 1,500 crore and the premium amount paid towards purchase of the above NCDs are expensed off as an exceptional items in the aforesaid results for the year ended March 31, 2021," Zydus Wellness said.

The company's total revenue rose 5.5 per cent to Rs 1,875 crore during FY21.

All you need to know about DRDO's new anti-COVID-19 drug 2-DG

Read more!
Advertisement